Sedation, Analgesia, and Muscle Relaxation During VV-ECMO Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2): A Single-Center, Retrospective, Observational Study

Objective: The pharmacokinetics and pharmacodynamics of ECMO-supported sedative, analgesic, and muscle relaxants have changed, but there are insufficient data to determine the optimal dosing strategies for these agents. Sedation, analgesia and muscle relaxation therapy for patients with severe acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fang, Li, Mingna, Zhang, Zhongwei, Shang, Jiawei, Guo, Yong, Li, Yingchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718548/
https://www.ncbi.nlm.nih.gov/pubmed/34977069
http://dx.doi.org/10.3389/fmed.2021.762740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718548/
https://www.ncbi.nlm.nih.gov/pubmed/34977069
http://dx.doi.org/10.3389/fmed.2021.762740

Ejemplares similares